ContraVir Pharmaceuticals announces name change to Hepion Pharmaceuticals
ContraVir Pharmaceuticals announced that its Board of Directors has approved the change of the Company’s name and stock symbol to Hepion Pharmaceuticals, Inc. and “HEPA,” respectively. The Company’s new NASDAQ trading symbol will be effective as of the opening of trading on July 23, 2019. July 22, 2019